Molecular genetic analysis of 103 sporadic colorectal tumours in czech patients

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Vasovcak, Peter ^a   Pavlikova, Kristyna ^a   Sedlacek, Zdenek ^a   Skapa, Petr ^a   Kouda, Martin ^a   Hoch, Jiri ^a   Krepelova, Anna ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; APC GENE; ARTICLE; BRAF GENE; CANCER GRADING; CANCER INVASION; CANCER STAGING; CODON; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; CTNNB1 GENE; CZECH REPUBLIC; DNA METHYLATION; FEMALE; FRAMESHIFT MUTATION; GENE; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GERMLINE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; KRAS GENE; LYMPHATIC INVASION; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MISSENSE MUTATION; MLH1 GENE; MUTATION RATE; MUTATIONAL ANALYSIS; MUTYH GENE; NONSENSE MUTATION; NUCLEIC ACID BASE SUBSTITUTION; PROMOTER REGION; SEX DIFFERENCE; SOMATIC MUTATION; TP53 GENE; CAUCASIAN; COLORECTAL TUMOR; GENETICS; MIDDLE AGED; MUTATION;

APC PROTEIN; APC PROTEIN, HUMAN; B RAF KINASE; BETA CATENIN; BRAF PROTEIN, HUMAN; CTNNB1 PROTEIN, HUMAN; DNA GLYCOSYLASE MUTY; DNA GLYCOSYLTRANSFERASE; KRAS PROTEIN, HUMAN; MLH1 PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN; PROTEIN P53; RAS PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOMATOUS POLYPOSIS COLI PROTEIN; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; COLORECTAL NEOPLASMS; CZECH REPUBLIC; DNA GLYCOSYLASES; DNA METHYLATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GERM-LINE MUTATION; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 80052049486     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024114     Document Type: Article

References (51)

1. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, et al. (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18: 581-592.
2. Bodmer WF, (2006) Cancer genetics: colorectal cancer as a model. J Hum Genet 51: 391-396.
3. Aretz S, (2010) The differential diagnosis and surveillance of hereditary gastrointestinal polyposis syndromes. Dtsch Arztebl Int 107: 163-173.
4. Al-Tassan N, Chmiel NH, Maynard J, Fleming N, Livingston AL, et al. (2002) Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors. Nat Genet 30: 227-232.
5. Poulsen ML, Bisgaard ML, (2008) MUTYH Associated Polyposis (MAP). Curr Genomics 9: 420-435.
6. Sulova M, Zidkova K, Kleibl Z, Stekrova J, Kebrdlova V, et al. (2007) Mutation analysis of the MYH gene in unrelated Czech APC mutation-negative polyposis patients. Eur J Cancer 43: 1617-1621.
7. Miyoshi Y, Nagase H, Ando H, Horii A, Ichii S, et al. (1992) Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet 1: 229-233.
8. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, et al. (1993) Clues to the pathogenesis of familial colorectal cancer. Science 260: 812-816.
9. Kitaeva MN, Grogan L, Williams JP, Dimond E, Nakahara K, et al. (1997) Mutations in beta-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors. Cancer Res 57: 4478-4481.
10. Sparks AB, Morin PJ, Vogelstein B, Kinzler KW, (1998) Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 58: 1130-1134.
11. Fearon ER, Vogelstein B, (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759-767.
12. Greenblatt MS, Bennett WP, Hollstein M, Harris CC, (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878.
13. de la Chapelle A, Hampel H, (2010) Clinical relevance of microsatellite instability in colorectal cancer. J Clin Oncol 28: 3380-3387.
14. Deng G, Bell I, Crawley S, Gum J, Terdiman JP, et al. (2004) BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer. Clin Cancer Res 10: 191-195.
15. Samowitz WS, Slattery ML, Sweeney C, Herrick J, Wolff RK, et al. (2007) APC mutations and other genetic and epigenetic changes in colon cancer. Mol Cancer Res 5: 165-170.
16. Pritchard CC, Grady WM, (2011) Colorectal cancer molecular biology moves into clinical practice. Gut 60: 116-129.
17. Ramensky V, Bork P, Sunyaev S, (2002) Human non-synonymous SNPs: server and survey. Nucleic Acids Res 30: 3894-3900.
18. Berg KD, Glaser CL, Thompson RE, Hamilton SR, Griffin CA, et al. (2000) Detection of microsatellite instability by fluorescence multiplex polymerase chain reaction. J Mol Diagn 2: 20-28.
19. Center MM, Jemal A, Ward E (2009) International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev 18: 1688-1694.
20. Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, et al. (1992) APC mutations occur early during colorectal tumorigenesis. Nature 359: 235-237.
21. Lamlum H, Ilyas M, Rowan A, Clark S, Johnson V, et al. (1999) The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis. Nat Med 5: 1071-1075.
22. Rowan AJ, Lamlum H, Ilyas M, Wheeler J, Straub J, et al. (2000) APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits". Proc Natl Acad Sci U S A 97: 3352-3357.
23. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, et al. (1997) Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 275: 1784-1787.
24. Farrington SM, Tenesa A, Barnetson R, Wiltshire A, Prendergast J, et al. (2005) Germline susceptibility to colorectal cancer due to base-excision repair gene defects. Am J Hum Genet 77: 112-119.
25. Isidro G, Laranjeira F, Pires A, Leite J, Regateiro F, et al. (2004) Germline MUTYH (MYH) mutations in Portuguese individuals with multiple colorectal adenomas. Hum Mutat 24: 353-354.
26. Jenkins MA, Croitoru ME, Monga N, Cleary SP, Cotterchio M, et al. (2006) Risk of colorectal cancer in monoallelic and biallelic carriers of MYH mutations: a population-based case-family study. Cancer Epidemiol Biomarkers Prev 15: 312-314.
27. Lubbe SJ, Di Bernardo MC, Chandler IP, Houlston RS, (2009) Clinical implications of the colorectal cancer risk associated with MUTYH mutation. J Clin Oncol 27: 3975-3980.
28. Peterlongo P, Mitra N, Chuai S, Kirchhoff T, Palmer C, et al. (2005) Colorectal cancer risk in individuals with biallelic or monoallelic mutations of MYH. Int J Cancer 114: 505-507.
29. Rajagopalan H, Bardelli A, Lengauer C, Kinzler KW, Vogelstein, et al. (2002) Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature 418: 934.
30. Thibodeau SN, French AJ, Cunningham JM, Tester D, Burgart LJ, et al. (1998) Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res 58: 1713-1718.
31. Samowitz WS, Curtin K, Wolff RK, Tripp SR, Caan BJ, et al. (2009) Microsatellite instability and survival in rectal cancer. Cancer Causes Control 20: 1763-1768.
32. Kim YH, Min BH, Kim SJ, Choi HK, Kim KM, et al. (2010) Difference between proximal and distal microsatellite-unstable sporadic colorectal cancers: analysis of clinicopathological and molecular features and prognoses. Ann Surg Oncol 17: 1435-1441.
33. Oliveira C, Velho S, Moutinho C, Ferreira A, Preto A, et al. (2007) KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression. Oncogene 26: 158-163.
34. de Vogel S, Weijenberg MP, Herman JG, Wouters KA, de Goeij AF, et al. (2009) MGMT and MLH1 promoter methylation versus APC, KRAS and BRAF gene mutations in colorectal cancer: indications for distinct pathways and sequence of events. Ann Oncol 20: 1216-1222.
35. Domingo E, Espin E, Armengol M, Oliveira C, Pinto M, et al. (2004) Activated BRAF targets proximal colon tumors with mismatch repair deficiency and MLH1 inactivation. Genes Chromosomes Cancer 39: 138-142.
36. Huang J, Papadopoulos N, McKinley AJ, Farrington SM, Curtis LJ, et al. (1996) APC mutations in colorectal tumors with mismatch repair deficiency. Proc Natl Acad Sci U S A 93: 9049-9054.
37. Knai C, Suhrcke M, Lobstein T, (2007) Obesity in Eastern Europe: an overview of its health and economic implications. Econ Hum Biol 5: 392-408.
38. Jackson MA, Lea I, Rashid A, Peddada SD, Dunnick JK, (2006) Genetic alterations in cancer knowledge system: analysis of gene mutations in mouse and human liver and lung tumors. Toxicol Sci 90: 400-418.
39. Sugimura T, Wakabayashi K, Nakagama H, Nagao M, (2004) Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish. Cancer Sci 95: 290-299.
40. Phillips DH, (1999) Polycyclic aromatic hydrocarbons in the diet. Mutat Res 443: 139-147.
41. Kazerouni N, Sinha R, Hsu CH, Greenberg A, Rothman N, (2001) Analysis of 200 food items for benzo[a]pyrene and estimation of its intake in an epidemiologic study. Food Chem Toxicol 39: 423-436.
42. Dofkova M, Kopriva V, Resova D, Rehurkova I, Ruprich J, (2001) The development of food consumption in the Czech Republic after 1989. Public Health Nutr 4: 999-1003.
43. Pardini B, Naccarati A, Novotny J, Smerhovsky Z, Vodickova L, et al. (2008) DNA repair genetic polymorphisms and risk of colorectal cancer in the Czech Republic. Mutat Res 638: 146-153.
44. Biggs PJ, Warren W, Venitt S, Stratton MR, (1993) Does a genotoxic carcinogen contribute to human breast cancer? The value of mutational spectra in unravelling the aetiology of cancer. Mutagenesis 8: 275-283.
45. Smith G, Carey FA, Beattie J, Wilkie MJ, Lightfoot TJ, et al. (2002) Mutations in APC, Kirsten-ras, and p53--alternative genetic pathways to colorectal cancer. Proc Natl Acad Sci U S A 99: 9433-9438.
46. Kinzler KW, Vogelstein B, (1996) Lessons from hereditary colorectal cancer. Cell 87: 159-170.
47. Kambara T, Simms LA, Whitehall VL, Spring KJ, Wynter CV, et al. (2004) BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 53: 1137-1144.
48. Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, et al. (2005) Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352: 1851-1860.
49. Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, et al. (2007) Patterns of somatic mutation in human cancer genomes. Nature 446: 153-158.
50. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, et al. (2007) The genomic landscapes of human breast and colorectal cancers. Science 318: 1108-1113.
51. Leary RJ, Lin JC, Cummins J, Boca S, Wood LD, et al. (2008) Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers. Proc Natl Acad Sci U S A 105: 16224-16229.